Moderna (MRNA) stock returned 677.7% in the twelve months starting October 24, 2025 and ending October 27, 2026, against 15.0 ...

A personalized melanoma vaccine, called intismeran, could mark a major advance in cancer treatment. Last week, pharmaceutical ...

Cardiologists with Henry Ford Hospital recently performed pulmonary artery denervation on two adults with pulmonary ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free ...

Pfizer (NYSE:PFE) reported positive Phase 3 MagnetisMM-32 results for ELREXFIO in relapsed or refractory multiple myeloma.

Cancer medicine had an extraordinary weekend in Madrid. At the European Society for Medical Oncology Congress, Amgen’s ...